Theriva Biologics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $9.6M | $17.5M |
| FY2015 | — | $16.1M | $20.8M |
| FY2016 | — | $3.8M | $19.1M |
| FY2017 | — | $-1.5M | $17.1M |
| FY2018 | — | $17.1M | $28.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $9.6M | $17.5M |
| FY2015 | — | $16.1M | $20.8M |
| FY2016 | — | $3.8M | $19.1M |
| FY2017 | — | $-1.5M | $17.1M |
| FY2018 | — | $17.1M | $28.9M |